松果菊苷通过Nrf2/HO-1通路抑制IL-1β诱导的软骨细胞铁死亡

doi:10.19586/j.2095-2341.2025.0043

生物技术进展 ›› 2025, Vol. 15 ›› Issue (4): 720-725.DOI: 10.19586/j.2095-2341.2025.0043

• 研究论文 • 上一篇

松果菊苷通过Nrf2/HO-1通路抑制IL-1β诱导的软骨细胞铁死亡

梁传财¹(), 邱波²()

^1.武汉大学人民医院急诊科，武汉 430060
^2.武汉大学人民医院关节外科，武汉 430060

收稿日期:2025-03-27 接受日期:2025-05-07 出版日期:2025-07-25 发布日期:2025-09-08
通讯作者: 邱波
作者简介:梁传财 E-mail: 2020283020228@whu.edu.cn；
基金资助:
国家自然科学基金项目(81071494)

Echinoside Inhibits IL-1β-induced Chondrocytes Iron Death Through Nrf2/HO-1 Pathway

Chuancai LIANG¹(), Bo QIU²()

^1.Department of Emergency，Wuhan University Renmin Hospital，Wuhan 430060，China
^2.Department of Orthopedics，Wuhan University Renmin Hospital，Wuhan 430060，China

Received:2025-03-27 Accepted:2025-05-07 Online:2025-07-25 Published:2025-09-08
Contact: Bo QIU

摘要/Abstract

摘要：

探讨了松果菊苷（echinacoside，ECH）对白细胞介素-1β（interleukin-1β， IL-1β）诱导的软骨细胞铁死亡的影响及其作用机制。提取Wistar大鼠软骨细胞，实验分为对照组、IL-1β组、ECH+IL-1β组、ECH+IL-1β+Brusatol(Nrf2抑制剂)组和ECH+IL-1β+ZnPP（HO-1抑制剂）5组。采用qPCR和Western Blot技术检测核因子E2相关因子2（nuclear factor-erythroid 2-related factor-2，Nrf2）、血红素氧合酶-1（heme oxygenase-1，HO-1）、酯酰辅酶A合成酶长链家族成员4（acyl-CoA synthetase long-chain familymember4，ACSL4）和谷胱甘肽过氧化酶4（glutathione peroxidase 4，GPX4）mRNA和蛋白表达量。结果显示，与对照组相比，IL-1β组中Nrf2、HO-1、GPX4的mRNA和蛋白表达量明显降低，ACSL4的mRNA和蛋白表达量明显升高。ECH组（ECH+IL-1β）中Nrf2、HO-1、GPX4的mRNA和蛋白表达量明显升高，ACSL4 的mRNA和蛋白表达量明显降低。在ECH组加入Nrf2抑制剂Brusatol或HO-1抑制剂ZnPP后，软骨细胞Nrf2、HO-1和GPX4的mRNA和蛋白表达量明显下降，ACSL4的mRNA和蛋白表达量明显升高。Fe²⁺检测试剂盒结果显示：与对照组相比，IL-1β组软骨细胞Fe²⁺含量明显升高；与IL-1β组相比，ECH组（ECH+IL-1β）软骨细胞Fe²⁺的含量明显降低，而在加入Nrf2抑制剂Brusatol或HO-1抑制剂ZnPP后软骨细胞Fe²⁺的含量明显升高。结果表明，松果菊苷通过Nrf2/HO-1通路可明显改善IL-1β诱导的软骨细胞铁死亡。

关键词: 骨关节炎, 铁死亡, 松果菊苷, 核因子E2相关因子2, 血红素氧合酶-1

Abstract:

To investigate the protective mechanism of echinacoside （ECH） in interleukin-1β （IL-1β）-induced chondrocyte iron death. Wistar mammary rat chondrocytes were extracted， and the experiment was divided into 5 groups： control group， IL-1β group， ECH+IL-1β group， ECH+IL-1β+Brusatol （Nrf2 inhibitor） group and ECH+IL-1β+ZnPP （HO-1 inhibitor） group. Quantitative PCR （qPCR） and Western Blot were used to detect mRNA and protein expression nuclear factor E2-related factor 2 （Nrf2）， heme oxygenase-1 （HO-1）， esteroyl coenzyme A synthase long-chain family member 4 （ACSL4） and glutathione peroxidase 4 （GPX4）， respectively. The results showed that the mRNA and protein expression of Nrf2， HO-1 and GPX4 were significantly reduced in the IL-1β group， and the mRNA and protein expression of ACSL4 were significantly enhanced compared with the control group. The mRNA and protein expression of cartilage Nrf2， HO-1 and GPX4 were significantly decreased and that of ACSL4 was significantly enhanced by the addition of the Nrf2 inhibitor Brusatol or the HO-1 inhibitor ZnPP in the ECH group. The results of Fe²⁺ Assay Kit showed that the chondrocyte Fe²⁺ content was significantly higher in the IL-1β group compared to the control group. The chondrocyte Fe²⁺ content was significantly lower in the ECH group （ECH+IL-1β） compared to the IL-1β group， while it was significantly higher in the ECH group after the addition of the Nrf2 inhibitor Brusatol or the HO-1 inhibitor ZnPP. The results suggest that echinoside can significantly improve IL-1β-induced chondrocyte iron death through Nrf2/HO-1 pathway.

Key words: osteoarthritis, iron death, echinoside, nuclear factor E2-related factor 2, heme oxygenase-1

中图分类号:

Q291

梁传财, 邱波. 松果菊苷通过Nrf2/HO-1通路抑制IL-1β诱导的软骨细胞铁死亡[J]. 生物技术进展, 2025, 15(4): 720-725.

Chuancai LIANG, Bo QIU. Echinoside Inhibits IL-1β-induced Chondrocytes Iron Death Through Nrf2/HO-1 Pathway[J]. Current Biotechnology, 2025, 15(4): 720-725.

图/表 5

参考文献 24

[1]	HE M, ZHONG X, LI Z, et al.. Progress in the treatment of knee osteoarthritis with high tibial osteotomy: a systematic review[J/OL]. Syst. Rev., 2021, 10(1): 56[2025-05-06]. .
[2]	STOCKWELL B R, JIANG X, GU W. Emerging mechanisms and disease relevance of ferroptosis[J]. Trends. Cell Biol., 2020, 30(6): 478-490.
[3]	JIANG X, STOCKWELL B R, CONRAD M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat. Rev. Mol. Cell Biol., 2021, 22(4): 266-282.
[4]	DIXON S J, LEMBERG K M, LAMPRECHT M R, et al.. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
[5]	STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al.. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell, 2017, 171(2): 273-285.
[6]	YAN J, FENG G, MA L, et al.. Metformin alleviates osteoarthritis in mice by inhibiting chondrocyte ferroptosis and improving subchondral osteosclerosis and angiogenesis[J/OL]. J. Orthop. Surg. Res., 2022, 17(1): 333[2025-05-06]. .
[7]	GUO Z, LIN J, SUN K, et al.. Corrigendum: deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway [J]. Front. Pharmacol., 2023, 14: 1199951[2025-05-06]. .
[8]	LOBODA A, DAMULEWICZ M, PYZA E, et al.. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism[J]. Cell. Mol. Life Sci., 2016, 73(17): 3221-3247.
[9]	STEWART J D, HENGSTLER J G, BOLT H M. Control of oxidative stress by the Keap1-Nrf2 pathway[J/OL]. Arch. Toxicol., 2011, 85(4): 239[2025-05-06]. .
[10]	JIANG T, CHENG H, SU J, et al.. Gastrodin protects against glutamate-induced ferroptosis in HT-22 cells through Nrf2/HO-1 signaling pathway[J/OL]. Toxicol. Vitro, 2020, 62: 104715[2025-05-06]. .
[11]	DONG H, QIANG Z, CHAI D, et al.. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1[J]. Aging, 2020, 12(13): 12943-12959.
[12]	DING Q H, YE C Y, CHEN E M, et al.. Emodin ameliorates cartilage degradation in osteoarthritis by inhibiting NF-κB and Wnt/β-catenin signaling in-vitro and in-vivo [J]. Int. Immunopharmacol., 2018, 61: 222-230.
[13]	LIANG Y, WANG Y, ZHANG Y, et al.. HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer[J/OL]. Cell Death Dis., 2023, 14(7): 434[2025-05-06]. .
[14]	LIN Z, TENG C, NI L, et al.. Echinacoside upregulates Sirt1 to suppress endoplasmic reticulum stress and inhibit extracellular matrix degradation in vitro and ameliorates osteoarthritis in vivo [J/OL]. Oxid. Med. Cell. Longev., 2021, 2021: 3137066[2025-05-06]. .
[15]	VINCENT T L. Mechanoflammation in osteoarthritis pathogenesis[J/OL]. Semin. Arthritis Rheum., 2019, 49(): 36-38.
[16]	SUN X, OU Z, XIE M, et al.. HSPB1 as a novel regulator of ferroptotic cancer cell death[J]. Oncogene, 2015, 34(45): 5617-5625.
[17]	SGARBOSSA A, BOSCO M, PRESSI G, et al.. Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors[J]. Chem. Biol. Interact., 2012, 199(2): 87-95.
[18]	YANG W S, SRIRAMARATNAM R, WELSCH M E, et al.. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2): 317-331.
[19]	LI Y, FENG D, WANG Z, et al.. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion[J]. Cell Death Differ., 2019, 26(11): 2284-2299.
[20]	TAN Z, ZHANG B. Echinacoside alleviates osteoarthritis in rats by activating the Nrf2-HO-1 signaling pathway[J]. Immunopharmacol. Immunotoxicol., 2022, 44(6): 850-859.
[21]	ZHANG F, YAN Y, PENG W, et al.. PARK7 promotes repair in early steroid-induced osteonecrosis of the femoral head by enhancing resistance to stress-induced apoptosis in bone marrow mesenchymal stem cells via regulation of the Nrf2 signaling pathway[J/OL]. Cell Death Dis., 2021, 12(10): 940[2025-05-06]. .
[22]	DODSON M, CASTRO-PORTUGUEZ R, ZHANG D D. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis[J/OL]. Redox Biol., 2019, 23: 101107[2025-05-06]. .
[23]	ZHANG M, ZHANG R, ZHENG T, et al.. Xanthohumol attenuated inflammation and ECM degradation by mediating HO-1/C/EBPβ pathway in osteoarthritis chondrocytes[J/OL]. Front. Pharmacol., 2021, 12: 680585[2025-05-06]. .
[24]	ANDREAS M, OESER C, MKAINZ F, et al.. Intravenous heme arginate induces HO-1 (heme oxygenase-1) in the human heart[J]. Arterioscler. Thromb. Vasc. Biol., 2018, 38(11): 2755-2762.

目的基因	引物序列（5′→3′）
GAPDH	F: 5′-ACAGCAACAGGGTGGTGGAC-3′
	R: 5′-TTTGAGGGTGCAGCGAACTT-3′
HO-1	F:5′-ACATCGACAGCCCCACCAAGTTCAA-3′
	R:5′-CTGACGAAGTGACGCCATCTGTGAG-3′
Nrf2	F:5′-TCCTCCTCGCTGGAAAAAGAA-3′
	R:5′-AATGTGCTGGCTGTGCTTTA-3′
GPX4	F:5′-ACCTGGACGCCAAAGTCCTA-3′
	R:5′-GTGACGATGCACACGAAACC-3′
ACSL4	F:5′-CAAGGGAGGCTTTAGGCGAC-3′
	R:5′-GCTCACTAAGGACGTCACCG-3′

目的基因	引物序列（5′→3′）
GAPDH	F: 5′-ACAGCAACAGGGTGGTGGAC-3′
	R: 5′-TTTGAGGGTGCAGCGAACTT-3′
HO-1	F:5′-ACATCGACAGCCCCACCAAGTTCAA-3′
	R:5′-CTGACGAAGTGACGCCATCTGTGAG-3′
Nrf2	F:5′-TCCTCCTCGCTGGAAAAAGAA-3′
	R:5′-AATGTGCTGGCTGTGCTTTA-3′
GPX4	F:5′-ACCTGGACGCCAAAGTCCTA-3′
	R:5′-GTGACGATGCACACGAAACC-3′
ACSL4	F:5′-CAAGGGAGGCTTTAGGCGAC-3′
	R:5′-GCTCACTAAGGACGTCACCG-3′

组别	Nrf2	HO-1	GPX4	ACSL4
对照组	0.847±0.094^*	0.861±0.109^*	0.836±0.101^*	0.587±0.071^*
IL-1β组	0.381±0.049	0.458±0.027	0.402±0.047	1.373±0.068
ECH+IL-1β组	0.612±0.034^*	0.657±0.026^*	0.632±0.092^*	0.581±0.076^*
ECH+IL-1β+Brusatol组	0.349±0.055^#	0.367±0.066^#	0.415±0.071^#	0.911±0.036^#
ECH+IL-1β+ZnPP组	0.363±0.015^#	0.381±0.014^#	0.323±0.014^#	0.935±0.095^#
F值	45	140	25	59
P值	<0.05	<0.05	<0.05	<0.05

组别	Nrf2	HO-1	GPX4	ACSL4
对照组	0.847±0.094^*	0.861±0.109^*	0.836±0.101^*	0.587±0.071^*
IL-1β组	0.381±0.049	0.458±0.027	0.402±0.047	1.373±0.068
ECH+IL-1β组	0.612±0.034^*	0.657±0.026^*	0.632±0.092^*	0.581±0.076^*
ECH+IL-1β+Brusatol组	0.349±0.055^#	0.367±0.066^#	0.415±0.071^#	0.911±0.036^#
ECH+IL-1β+ZnPP组	0.363±0.015^#	0.381±0.014^#	0.323±0.014^#	0.935±0.095^#
F值	45	140	25	59
P值	<0.05	<0.05	<0.05	<0.05

组别	Nrf2	HO-1	GPX4	ACSL4
对照组	1.153±0.107^*	1.014±0.141^*	1.019±0.041^*	1.162±0.151^*
IL-1β组	0.443±0.070	0.414±0.017	0.436±0.026	3.236±0.252
ECH+IL-1β组	0.906±0.032^*	0.793±0.051^*	0.782±0.094^*	1.64±0.086^*
ECH+IL-1β+Brusatol组	0.656±0.075^#	0.618±0.053^#	0.611±0.012^#	2.024±0.246^#
ECH+IL-1β+ZnPP组	0.613±0.021^#	0.585±0.018^#	0.619±0.031^#	2.564±0.116^#
F值	48	77	51	91
P值	<0.05	<0.05	<0.05	<0.05

松果菊苷通过Nrf2/HO-1通路抑制IL-1β诱导的软骨细胞铁死亡

Echinoside Inhibits IL-1β-induced Chondrocytes Iron Death Through Nrf2/HO-1 Pathway

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 5

参考文献 24

相关文章 14

编辑推荐

Metrics

本文评价

组别	Fe²⁺含量/(μmol·mL^-1)	细胞增殖率/%
对照组	110.1±7.1^*	81.3±5.3^*
IL-1β组	424.3±30.4	53.4±7.1
ECH+IL-1β组	266.0±12.3^*	75.9±4.7^*
ECH+IL-1β+Brusatol组	371.2±25.1^#	60.2±3.2^#
ECH+IL-1β+ZnPP组	362.5±21.7^#	57.5±6.2^#
F值	103	68
P值	<0.05	<0.05

[1]	王彦杰, 邱波. P53基因在骨肉瘤中的作用与研究进展[J]. 生物技术进展, 2025, 15(2): 241-246.
[2]	张明娇, 朱杰夫, 吴雄飞. 顺铂诱导的肾损伤中的细胞死亡[J]. 生物技术进展, 2023, 13(5): 718-724.
[3]	王珍, 黄克让, 陈蕾, 周敏, 薛元夏. 应用高压冷冻-冷冻替代技术研究Erastin对颗粒细胞超微结构的影响[J]. 生物技术进展, 2023, 13(4): 637-644.
[4]	王彦容, 郭元彪. 基于铁死亡相关LncRNA构建肝细胞癌预后模型的研究[J]. 生物技术进展, 2023, 13(3): 473-481.
[5]	曹静钰, 刘承梅, 祁晨旭, 杜开颜, 陈蒙, 侯思伟. Nrf2在脊髓损伤后铁死亡的研究进展[J]. 生物技术进展, 2023, 13(2): 240-246.
[6]	杜开颜, 祁晨旭, 曹静钰, 陈蒙, 高静, 刘承梅. 铁死亡参与脊髓损伤调控的研究进展[J]. 生物技术进展, 2022, 12(6): 869-874.
[7]	姚佳炜, 邱波. 骨关节炎滑膜病变的体液标志物研究进展[J]. 生物技术进展, 2022, 12(3): 373-378.
[8]	梁传财, 邱波. 低强度脉冲超声在骨关节炎研究中的应用进展[J]. 生物技术进展, 2022, 12(2): 243-247.
[9]	廖敏, 杨洛, 王珍, 郝亚荣. 松果菊苷对db/db糖尿病小鼠心肌的保护作用[J]. 生物技术进展, 2022, 12(1): 129-134.
[10]	金童, 陈铖. 铁死亡与肾脏疾病相关性的研究进展[J]. 生物技术进展, 2022, 12(1): 68-74.
[11]	梁传财, 易鹏, 邱波. AMPK/SIRT1/PPARγ/PGC1α轴及其相关因子在骨关节炎脂质代谢中的作用[J]. 生物技术进展, 2021, 11(6): 718-723.
[12]	胡勇, 杨俭, 邱波. 半乳糖凝集素‑3对骨关节炎成骨细胞矿化的作用研究[J]. 生物技术进展, 2021, 11(6): 802-806.
[13]	邢亨特,邱波. 富血小板血浆注射治疗在膝骨关节炎中的应用进展[J]. 生物技术进展, 2021, 11(2): 163-169.
[14]	徐雄峰,邱波,李华杰,易鹏. 壳聚糖薄膜培养对脐带间充质干细胞抗炎基因表达的影响[J]. 生物技术进展, 2019, 9(4): 404-408.